Arrowstreet Capital
FATE icon

Arrowstreet Capital’s Fate Therapeutics FATE Stock Holding History

Arrowstreet Capital’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-25,580
Closed -$42.2K – 1867
2024
Q4 		$42.2K Sell
25,580
-6,518
-20% -$16.4K ﹤0.01% 1700
2024
Q3 		$112K Buy
+32,098
New +$125K ﹤0.01% 1679
2021
Q4 		– Sell
-25,100
Closed -$1.49M – 1522
2021
Q3 		$1.49M Buy
25,100
+21,300
+561% +$1.67M ﹤0.01% 1203
2021
Q2 		$330K Buy
+3,800
New +$306K ﹤0.01% 1732
2021
Q1 		– Sell
-69,636
Closed -$6.33M – 2323
2020
Q4 		$6.33M Buy
69,636
+35,477
+104% +$2.2M 0.01% 1101
2020
Q3 		$1.36M Buy
+34,159
New +$1.19M ﹤0.01% 1710
2020
Q1 		– Sell
-31,900
Closed -$624K – 1942
2019
Q4 		$624K Buy
+31,900
New +$507K ﹤0.01% 1447
2019
Q2 		– Sell
-19,300
Closed -$339K – 1480
2019
Q1 		$339K Buy
19,300
+8,530
+79% +$135K ﹤0.01% 1564
2018
Q4 		$138K Buy
+10,770
New +$150K ﹤0.01% 1283

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return